-
Medicure Announces FDA Approval Received for Prexxartan®
Tuesday, December 19, 2017
View article
-
Medicure Acquires Exclusive License to Sell and Market Branded Cardiovascular Drug in the U.S.
Thursday, December 14, 2017
View article
-
Medicure Reports Financial Results for Quarter Ended September 30, 2017
Tuesday, November 21, 2017
View article
-
Medicure Announces Repayment of Outstanding Debt
Friday, November 17, 2017
View article
-
Medicure Q3 Results and Conference Call Dates
Wednesday, November 15, 2017
View article
-
Medicure Acquires Exclusive License to Sell and Market PREXXARTAN® in the U.S. from Carmel Biosciences
Tuesday, October 31, 2017
View article
-
Medicure Announces Sale of Apicore Business
Tuesday, October 3, 2017
View article
-
Medicure Reports Financial Results for Quarter Ended June 30, 2017
Monday, August 7, 2017
View article
-
Medicure Q2 Results and Conference Call Dates
Wednesday, August 2, 2017
View article
-
Medicure Closes Acquisition of Additional Interests in Apicore
Wednesday, July 12, 2017
View article
-
Medicure Exercises Option to Acquire Additional Interests in Apicore
Monday, July 10, 2017
View article
-
Medicure Provides Update on Apicore Purchase Option
Monday, July 3, 2017
View article
-
Medicure Reports Financial Results for Quarter Ended March 31, 2017
Wednesday, May 24, 2017
View article
-
Medicure Q1 Results and Conference Call Dates
Thursday, May 18, 2017
View article
-
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2016
Wednesday, April 26, 2017
View article
-
Medicure to Announce Fiscal Year End 2016 Financial Results on April 26, 2017
Wednesday, March 29, 2017
View article
-
Medicure Announces FDA Approval for Apicore's Generic Tetrabenazine
Thursday, March 23, 2017
View article
-
Medicure Provides Apicore Secured Loan to Replace Knight Loan
Monday, January 9, 2017
View article
-
Medicure announces filing of ANDA in collaboration with Apicore
Tuesday, December 13, 2016
View article
-
Medicure Closes Acquisition of Majority Interest in Apicore
Thursday, December 1, 2016
View article
-
Medicure to Hold Investor Call on November 21, 2016
Friday, November 18, 2016
View article
-
Medicure Exercises Option to Acquire Majority Interest in Apicore
Friday, November 18, 2016
View article
-
Medicure Reports Third Quarter 2016 Financial Results
Wednesday, November 9, 2016
View article
-
Medicure to Announce Q3 2016 Financial Results on November 9, 2016
Wednesday, November 2, 2016
View article
-
FDA Approves New AGGRASTAT® Product Format
Thursday, September 1, 2016
View article
-
Medicure Reports Second Quarter 2016 Financial Results
Wednesday, August 10, 2016
View article
-
Medicure to Announce Q2 2016 Financial Results on August 10, 2016
Wednesday, August 3, 2016
View article
-
Medicure Receives Response Letter from FDA on AGGRASTAT® sNDA for New Indication
Thursday, July 7, 2016
View article
-
Medicure Reports First Quarter 2016 Financial Results
Wednesday, May 11, 2016
View article
-
Medicure Files Application for New AGGRASTAT® Product Format
Wednesday, May 11, 2016
View article
-
Medicure Announces Departure of President and Chief Operating Officer
Monday, May 9, 2016
View article
-
Medicure to Announce Q1 2016 Financial Results on May 11, 2016
Wednesday, May 4, 2016
View article
-
Medicure Announces Grant of Options
Thursday, April 7, 2016
View article
-
Medicure Announces Upcoming Conference Presentations
Tuesday, April 5, 2016
View article
-
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2015
Wednesday, March 30, 2016
View article
-
Medicure To Announce Fiscal Year 2015 Financial Results on March 30, 2016
Wednesday, March 23, 2016
View article
-
Meta-Analysis of AGGRASTAT® (Tirofiban HCl) Presented at CRT 2016 Conference
Tuesday, February 23, 2016
View article
-
Medicure to present at Cantech Investment Conference
Thursday, January 21, 2016
View article
-
Medicure Announces Preliminary Revenue For Fiscal 2015
Monday, January 11, 2016
View article
-
Medicure announces ANDA collaboration with Apicore
Wednesday, January 6, 2016
View article
-
Medicure Announces PDUFA Action Date for New Aggrastat Indication
Wednesday, December 2, 2015
View article
-
Medicure Announces Grant of Stock Options
Wednesday, November 25, 2015
View article
-
Medicure Reports Third Quarter 2015 Financial Results
Monday, November 9, 2015
View article
-
Medicure Q3 Results and Conference Call Dates
Tuesday, November 3, 2015
View article
-
Medicure Announces Filing of sNDA for New AGGRASTAT® Indication
Thursday, September 10, 2015
View article
-
Medicure Reports Second Quarter 2015 Financial Results
Tuesday, August 11, 2015
View article
-
Medicure Q2 Results And Conference Call Dates
Wednesday, August 5, 2015
View article
-
Medicure Announces Grant Of Options
Tuesday, July 7, 2015
View article
-
Medicure Closes Bought Deal Private Placement Financing for Gross Proceeds of $4,025,000
Friday, June 26, 2015
View article
-
Medicure Announces $3.5 Million "Bought Deal" Private Placement
Wednesday, June 10, 2015
View article
